Alantolactone Attenuates Renal Fibrosis via Inhibition of Transforming Growth Factor β/Smad3 Signaling Pathway
Background Renal fibrosis is characterized by the accumulation of extracellular matrix proteins and interstitial fibrosis. Alantolactone is known to exert anticancer, anti-inflammatory, antimicrobial and antifungal effects; however, its effects on renal fibrosis remains unknown. Here, we investigate...
Main Authors: | Kyeong-Min Lee, Yeo Jin Hwang, Gwon-Soo Jung |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Diabetes Association
2024-01-01
|
Series: | Diabetes & Metabolism Journal |
Subjects: | |
Online Access: | http://e-dmj.org/upload/pdf/dmj-2022-0231.pdf |
Similar Items
-
The flavonoid fisetin ameliorates renal fibrosis by inhibiting SMAD3 phosphorylation, oxidative damage, and inflammation in ureteral obstructed kidney in mice
by: Ha Young Ju, et al.
Published: (2023-05-01) -
Verbascoside alleviates renal fibrosis in unilateral ureteral obstruction rats by inhibiting macrophage infiltration
by: Guihua Zhang, et al.
Published: (2021-06-01) -
Fluorofenidone inhibits apoptosis of renal tubular epithelial cells in rats with renal interstitial fibrosis
by: Hui Yang, et al.
Published: (2019-10-01) -
MicroRNA-302b mitigates renal fibrosis via inhibiting TGF-β/Smad pathway activation
by: Mengkui Sun, et al.
Published: (2021-01-01) -
Unilateral Ureteral Obstruction as a Model to Investigate Fibrosis-Attenuating Treatments
by: Elena Martínez-Klimova, et al.
Published: (2019-04-01)